Loading...
•
Dec 31, 2024
LifeMD Q4 2024 Earnings Report
LifeMD reported strong Q4 2024 results with significant revenue and adjusted EBITDA growth, driven by its telehealth segment.
Key Takeaways
LifeMD achieved record quarterly revenue and adjusted EBITDA in Q4 2024, with consolidated revenue increasing 43% year-over-year to $64.3 million and adjusted EBITDA increasing 78% to $9.0 million. The telehealth segment was a key driver, with revenue up 60% and adjusted EBITDA up 396%.
Consolidated revenues increased 43% year-over-year to $64.3 million, with telehealth revenue up 60%.
Adjusted EBITDA increased 78% to $9.0 million, and telehealth adjusted EBITDA increased 396% to $5.9 million.
Full-year cash flow from operations increased 99% to $17.5 million, generating positive full-year net cash flow.
The company exited 2024 with over $35 million in cash and introduced strong 2025 guidance for revenue and adjusted EBITDA.
Revenue by Segment
Forward Guidance
LifeMD provided strong guidance for both Q1 2025 and the full year 2025, anticipating continued growth in revenue and adjusted EBITDA, particularly within its telehealth segment.
Positive Outlook
- Q1 2025 total revenue expected in the range of $61 million to $63 million.
- Q1 2025 telehealth revenue expected in the range of $48 million to $49 million.
- Q1 2025 adjusted EBITDA expected in the range of $5 million to $7 million.
- Full-year 2025 consolidated revenue expected in the range of $265 million to $275 million.
- Full-year 2025 consolidated adjusted EBITDA expected in the range of $30 million to $32 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...